Current Issue - March 2026, Volume 20, Issue No. 1

1. Samardziski M, Zafiroski G, Tolevska C, Zafirova-Ivanovska B, Kostadinova-Kunovska S, Kalicanin-Markovska M. Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery). Prilozi. 2008; 29(2): 309-23.
2. Salter RB. Textbook of Disorders and Injuries of the Musculoskeletal System: An Introduction to Orthopaedics, Fractures, and Joint Injuries, Rheumatology, Metabolic Bone Disease, and Rehabilitation. 3rd ed. Lippincott Williams & Wilkins; 1999.
3. Prater S, McKeon B. Cancer, Osteosarcoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK549868/
4. Hameed M, Mandelker D. Tumor Syndromes Predisposing to Osteosarcoma. Adv Anat Pathol. 2018; 25(4): 217-22. doi: 10.1097/PAP.0000000000000190
5. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. 1986. J Bone Joint Surg Am. 2005; 87(12): 2822. doi: 10.2106/JBJS.8712.cl
6. Carty CP, Dickinson IC, Watts MC, Crawford RW, Steadman P. Impairment and disability following limb salvage procedures for bone sarcoma. Knee. 2009; 16(5): 405-8. doi: 10.1016/j.knee.2009.02.006
7. Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol. 2007; 19(4): 341-6. doi: 10.1097/CCO.0b013e328122d73f
8. Xu J, Xie L, Guo W. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma? Clin Orthop Relat Res. 2018; 476(11): 2177-86. doi: 10.1097/CORR.0000000000000387
9. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, et al. Characterization of a Human Osteosarcoma Cell Line (Saos-2) with Osteoblastic Properties. Cancer Res. 1987; 47(18): 4961-6.
10. Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Körholz D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998; 9(8): 893-9. doi: 10.1023/a:1008391103132
11. Misaghi A, Goldin A, Awad M, Kulidjian AA. Osteosarcoma: a comprehensive review. SICOT J. 2018; 4: 12. doi: 10.1051/sicotj/2017028
12. Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications. J Bone Joint Surg Am. 2002; 84(1): 49-57.
13. Abudu A, Sferopoulos NK, Tillman RM, Carter SR, Grimer RJ. The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg Br. 1996; 78-B(5): 694-8. doi:10.1302/0301-620X.78B5.0780694
14. Li X, Zhang Y, Wan S, Li H, Li D, Xia J, et al. A comparative study between limb-salvage and amputation for treating osteosarcoma. J Bone Oncol. 2016; 5(1): 15-21. doi: 10.1016/j.jbo.2016.01.001
15. Bacci G, Picci P, Ruggieri P, Mercuri M, Avella M, Capanna R, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer. 1990; 65(11): 2539-53. doi: 10.1002/1097-0142(19900601)65:11<2539::aid-cncr2820651125>3.0.co;2-m
16. Gherlinzoni F, Picci P, Bacci G, Campanacci D. Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. Ann Oncol. 1992; 3 Suppl 2: S23-7. doi: 10.1093/annonc/3.suppl_2.s23
17. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993; 72(11): 3227-38. doi: 10.1002/1097-0142(19931201)72:11<3227::aid-cncr2820721116>3.0.co;2-c
18. Bacci G, Ferrari S, Longhi A, Perin S, Forni C, Fabbri N, et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer. 2001; 37(1): 32-8. doi: 10.1016/s0959-8049(00)00361-0
19. Fujiwara T, Medellin MR, Sambri A, Tsuda Y, Balko J, Sumathi V, et al. Preoperative surgical risk stratification in osteosarcoma based on the proximity to the major vessels. Bone Joint J. 2019; 101-B(8): 1024-31. doi: 10.1302/0301-620X.101B8.BJJ-2018-0963.R1
20. Hegyi P, Pandol S, Venglovecz V, Rakonczay Z Jr. The acinar-ductal tango in the pathogenesis of acute pancreatitis. Gut. 2011; 60(4): 544-52. doi: 10.1136/gut.2010.218461
21. Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, et al. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2018; 36(18): 1813-22. doi: 10.1200/JCO.2017.74.0720
22. Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol. 2015; 33(27): 3029-35. doi: 10.1200/JCO.2014.59.4895
23. Bacci G, Ferrari S, Lari S, Mercuri M, Donati D, Longhi A, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br. 2002; 84(1): 88-92. doi: 10.1302/0301-620x.84b1.12211
24. Mavrogenis AF, Abati CN, Romagnoli C, Ruggieri P. Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res. 2012; 470(6): 1735-48. doi: 10.1007/s11999-011-2238-7
25. Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018; 18(1): 39-50. doi: 10.1080/14737140.2018.1413939
26. Sluga M, Windhager R, Lang S, Heinzl H, Bielack S, Kotz R. Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. Clin Orthop Relat Res. 1999; (358): 120-7.
27. Zhang Y, Yang J, Zhao N, Wang C, Kamar S, Zhou Y, et al. Progress in the chemotherapeutic treatment of osteosarcoma. Oncol Lett. 2018; 16(5): 6228-37. doi: 10.3892/ol.2018.9434

Abstract   |   Reference